Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

$885M IBS Drug Verdict Tests Pay-For-Delay Limits

Дата публикации: 30-06-2026 15:04:15

The outcome in the Amitiza Antitrust Litigation is significant because it is the first jury trial win for private antitrust plaintiffs in a suit challenging a patent settlement reverse payment since the U.S. Supreme Court adopted the rule-of-reason legal framework in 2013, offering a blueprint for pay-for-delay claims, say attorneys at Katten.

Основное содержимое страницы с новостью.

$885M IBS Drug Verdict Tests Pay-For-Delay Limits

By David Gonen, Brian Sodikoff and Eric Werlinger ( June 30, 2026, 3:04 PM EDT) -- A federal jury in Massachusetts returned a $885 million verdict against Takeda Pharmaceuticals Co., finding that Takeda entered into an anticompetitive patent settlement that compensated a generic manufacturer to delay launching a generic version of its irritable bowel syndrome drug Amitiza, or lubiprostone....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more0502-07-2026
2Zenas Wins Dismissal Of IPO Suit Over R&D Spending Claims0730-06-2026
3Court OKs Antitrust Deal Over Allegheny Health's Expansion0526-06-2026
4Bloomberg: Amazon просит суд приостановить контракт Пентагона с Microsoft на $10 млрд0023-01-2020
5Reuters: Amazon может оспорить передачу Microsoft контракта на $10 млрд0028-10-2019
6Justices' Penalty Ruling Won't Sink Tax Case, 5th Circ. Told0516-06-2026
7Zillow, Redfin Tell Court Their Partnership Is Not Illegal0525-06-2026
8NYT: Purdue Pharma выплатит $3 млрд первой группе истцов в связи с опиоидным кризисом0011-09-2019
9Visa i Mastercard kończą spór. To może mieć znaczenie dla milionów użytkowników kart0720-12-2025
10В Приватбанке заявили, что арбитраж Гааги отказал РФ в пересмотре иска о крымских активах0013-09-2019

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: www.law360.com.